C
Chao Zhou
Researcher at Peking Union Medical College
Publications - 26
Citations - 943
Chao Zhou is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Colonoscopy & Dosage form. The author has an hindex of 11, co-authored 25 publications receiving 564 citations.
Papers
More filters
Journal ArticleDOI
Effect of a deep-learning computer-aided detection system on adenoma detection during colonoscopy (CADe-DB trial): a double-blind randomised study.
Pu Wang,Xiaogang Liu,Tyler M. Berzin,Jeremy R. Glissen Brown,Peixi Liu,Chao Zhou,Lei Lei,Liangping Li,Zhenzhen Guo,Shan Lei,Fei Xiong,Han Wang,Yan Song,Yan Pan,Guanyu Zhou +14 more
TL;DR: The effectiveness of a CADe system that avoids potential operational bias during colonoscopy is assessed in a double-blind randomised trial at the endoscopy centre in Caotang branch hospital of Sichuan Provincial People's Hospital in China.
Journal ArticleDOI
Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics.
TL;DR: Results showed that the gut microbiota was altered in association with fecal metabolism in depressive conditions, and suggest that the 16S rRNA gene sequencing and LC–MS based metabolomics approach can be further applied to assess pathogenesis of depression.
Journal ArticleDOI
Chronic unpredictive mild stress leads to altered hepatic metabolic profile and gene expression.
Hong-Mei Jia,Qi Li,Chao Zhou,Meng Yu,Yong Yang,Hong-Wu Zhang,Gang Ding,Hai Shang,Zhong-Mei Zou +8 more
TL;DR: Results of liver-targeted metabonomics and mRNA expression demonstrated that CUMS-induced depression leads to variations in hepatic metabolic profile and gene expression, and ultimately results in liver injury.
Journal ArticleDOI
Urinary and Fecal Metabonomics Study of the Protective Effect of Chaihu-Shu-Gan-San on Antibiotic-Induced Gut Microbiota Dysbiosis in Rats.
TL;DR: A comprehensive understanding of the protective effects of CSGS on the host metabolic phenotype of the gut microbiota dysbiosis rats is provided, and a new source for drug leads in gut microbiota-targeted disease management is identified.
Journal ArticleDOI
Value of urinary KIM-1 and NGAL combined with serum Cys C for predicting acute kidney injury secondary to decompensated cirrhosis.
TL;DR: Urinary KIM-1, urinary NGAL, serum Cys C, and the combined detection factor, as screening indices, could aid in the early diagnosis of AKI secondary to decompensated cirrhosis.